Synthesis of boronic ester and acid compounds

Patent metadata

Field	Value
Publication number	US-10000529-B2
Application number	US-201715713005-A
Country	US
Kind code	B2
Filing date	Sep 22, 2017
Priority date	Mar 30, 2004
Publication date	Jun 19, 2018
Grant date	Jun 19, 2018

Abstract

The invention relates to the synthesis of boronic ester and acid compounds. More particularly, the invention provides improved synthetic processes for the large-scale production of boronic ester and acid compounds, including the peptide boronic acid proteasome inhibitor bortezomib.

First claim

What is claimed is:

1. A large-scale process for forming a compound of formula (XIV):

or a boronic acid anhydride thereof; the process comprises the steps:
(a) providing a boron “ate” complex of formula (XV):

wherein:
R 3 is a nucleofugic group;
Y is a nucleofugic group; and
M + is an alkali metal;
(b) contacting the boron “ate” complex of formula (XV) with a Lewis acid under conditions that afford a boronic ester compound of formula (XVI):

said contacting step being conducted in a reaction mixture comprising:
(i) a coordinating ether solvent that has low miscibility with water; or
(ii) an ether solvent that has low miscibility with water and a coordinating co-solvent, provided that the coordinating co-solvent constitutes no more than about 20% v/v of the reaction mixture;
wherein the solubility of water in the ether solvent in (i) or (ii) that has low miscibility with water is less than about 5% w/w; and
wherein the ether solvent in (i) or (ii) that has low miscibility with water constitutes at least about 70% v/v of the reaction mixture;
(c) treating the boronic ester compound of formula (XVI) with a reagent of formula M 1 -N(Si(R 6 ) 3 ) 2 , where M 1 is an alkali metal and each R 6 independently is selected from the group consisting of alkyl, aralkyl, and aryl, where the aryl or aryl portion of the aralkyl is optionally substituted, to form a compound of formula (XVII):

wherein each G is —Si(R 6 ) 3 ;
(d) removing the (R 6 ) 3 Si groups to form a compound of formula (XVIII):

or an acid addition salt thereof;
(e′) coupling the compound of formula (XVIII) with a compound of formula (XIXa):

wherein X is OH or a leaving group, to form a compound of formula (XXIII):

and
(f′) deprotecting the boronic acid moiety to form the compound of formula (XIV) or a boronic acid anhydride thereof.

2. The process of claim 1 , characterized by at least one of the following features (1)-(3):
(1) in the boron “ate” complex of formula (XV), R 3 and Y both are chloro;
(2) the coupling step (e′) comprises the steps:
(i) coupling the compound of formula (XVIII) with a compound of formula (XIXa) wherein X is OH in the presence of 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) and a tertiary amine in dichloromethane;
(ii) performing a solvent exchange to replace dichloromethane with ethyl acetate; and
(iii) performing an aqueous wash of the ethyl acetate solution;

(3) the boronic acid deprotecting step (f′) comprises the steps:
(i) providing a biphasic mixture comprising the compound of formula (XXIII), an organic boronic acid acceptor, a lower alkanol, a C 5-8 hydrocarbon solvent, and aqueous mineral acid;
(ii) stirring the biphasic mixture to afford the compound of formula (XIV);
(iii) separating the solvent layers; and
(iv) extracting the compound of formula (XIV), or a boronic acid anhydride thereof, into an organic solvent.

3. The process of claim 2 , wherein step (f′)(iii) comprises the steps:
(1) separating the solvent layers;
(2) adjusting the aqueous layer to basic pH;
(3) washing the aqueous layer with an organic solvent; and
(4) adjusting the aqueous layer to a pH less than about 8.

4. The process of claim 3 , wherein in step (f′)(iii)(3), the aqueous layer is washed with dichloromethane.

5. The process of claim 4 , wherein in step (f′)(iv), the compound of formula (XIV), or a boronic acid anhydride thereof, is extracted into dichloromethane, the solvent is exchanged to ethyl acetate, an the compound of formula (XIV), or a boronic acid anhydride thereof, is crystallized by addition of hexane or heptane.

6. The process of claim 5 , wherein addition of hexane or heptane results in crystallization of a cyclic trimeric boronic acid anhydride of formula (XXIV):

7. A process for forming a compound of formula (XIV):

or a boronic acid anhydride thereof, comprising the steps:
(a) coupling a compound of formula (XVIII):

or an acid addition salt thereof, with a compound of formula (XIXa):

wherein the moiety —C(O)X is an activated ester generated in situ by contacting N-(2-pyrazinecarbonyl)-L-phenylalanine with a peptide coupling reagent, to form a compound of formula (XXIII):

and
(b) deprotecting the boronic acid moiety to form the compound of formula (XIV) or a boronic acid anhydride thereof.

8. The process of claim 7 , wherein in the compound of formula (XIXa) the moiety C(O)—X is an O—(N-hydroxysuccinimide)ester.

9. The process of claim 8 , wherein the compound of formula (XIXa) is generated in situ by contacting N-(2-pyrazinecarbonyl)-L-phenylalanine with a carbodiimide peptide coupling reagent and N-hydroxysuccinimide.

10. The process of claim 9 , wherein the carbodiimide peptide coupling reagent is dicyclohexylcarbodiimide.

11. The process of claim 8 , wherein the coupling step (a) comprises the steps:
coupling an acid addition salt of a compound of formula (XVIII) with a compound of formula (XIXa), in the presence of N-methylmorpholine in DMF;
(ii) filtering the reaction mixture; and
(iii) concentrating the filtrate.

12. The process of claim 7 , wherein the boronic acid deprotecting step (b) comprises the steps:
(i) providing a biphasic mixture comprising the compound of formula (XXIII), an organic boronic acid acceptor, a lower alkanol, a C 5-8 hydrocarbon solvent, and aqueous mineral acid;
(ii) stirring the biphasic mixture to afford the compound of formula (XIV);
(iii) separating the solvent layers; and
(iv) extracting the compound of formula (XIV), or a boronic acid anhydride thereof, into an organic solvent.

13. The process of claim 12 , wherein step (b)(iii) comprises the steps:
(1) separating the solvent layers;
(2) adjusting the aqueous layer to basic pH;
(3) washing the aqueous layer with an organic solvent; and
(4) adjusting the aqueous layer to a pH less than 8.

14. The process of claim 13 , wherein in step (b)(iii)(4), the aqueous layer is adjusted to a pH less than 6.

15. The process of claim 12 , wherein in step (b)(iv), the compound of formula (XIV), or a boronic acid anhydride thereof, is extracted into ethyl acetate, and the compound of formula (XIV), or a boronic acid anhydride thereof, is crystallized by addition of hexane or heptane.

16. The process of claim 7 , wherein the process i

Assignees

• Millennium Pharm Inc

Inventors

• Ammoscato Vince
• Bishop John E
• Chiu Fang-Ting
• Geiser Achim
• Gomez Jean-Marc
• Hett Robert
• Koellner Christoph
• Kulkarni Vithalanand R
• Lo Young
• Munk Stephen
• Pickersgill I Fraser

Classifications

• A61P31/18

  for HIV · CPC title

• A61P37/06

  Immunosuppressants, e.g. drugs for graft rejection · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• C07F5/025 Primary

  Boronic and borinic acid compounds · CPC title